RZLT

$0.00

(

+0.00%

) Quote details
Add to Watchlist Run Backtest
stock

Rezolute Inc

NASDAQ | RZLT

9.72

USD

+$0.00

(

+0.00%

)

At Close (As of Nov 28, 2025)

$886.48M

Market Cap

-

P/E Ratio

-0.94

EPS

$11.46

52 Week High

$2.21

52 Week Low

HEALTHCARE

Sector

RZLT Chart

Recent Chart
Price Action

RZLT Technicals

Tags:

RZLT Earnings

Yearly Income Statement (As of Jun 30, 2025)

Field Value (USD)
Gross Profit -$31K
Total Revenue $0
Cost Of Revenue $31K
Costof Goods And Services Sold $31K
Operating Income -$80M
Selling General And Administrative $18M
Research And Development $62M
Operating Expenses $80M
Investment Income Net -
Net Interest Income $5.5M
Interest Income $5.5M
Interest Expense -
Non Interest Income -
Other Non Operating Income -
Depreciation -
Depreciation And Amortization $31K
Income Before Tax -$74M
Income Tax Expense -
Interest And Debt Expense -
Net Income From Continuing Operations -$74M
Comprehensive Income Net Of Tax -
Ebit -$80M
Ebitda -$80M
Net Income -$74M

Revenue & Profitability

Earnings Performance

RZLT Financials

yearly Balance Sheet (As of Jun 30, 2025)

Field Value (USD)
Total Assets $175M
Total Current Assets $171M
Cash And Cash Equivalents At Carrying Value $94M
Cash And Short Term Investments $94M
Inventory -
Current Net Receivables $700K
Total Non Current Assets $4.3M
Property Plant Equipment -
Accumulated Depreciation Amortization Ppe -
Intangible Assets -
Intangible Assets Excluding Goodwill -
Goodwill -
Investments -
Long Term Investments $0
Short Term Investments $74M
Other Current Assets $3.3M
Other Non Current Assets -
Total Liabilities $13M
Total Current Liabilities $12M
Current Accounts Payable $5.8M
Deferred Revenue -
Current Debt -
Short Term Debt $632K
Total Non Current Liabilities $1.5M
Capital Lease Obligations $1.6M
Long Term Debt -
Current Long Term Debt -
Long Term Debt Noncurrent -
Short Long Term Debt Total $1.6M
Other Current Liabilities $5.5M
Other Non Current Liabilities -
Total Shareholder Equity $162M
Treasury Stock -
Retained Earnings -$404M
Common Stock $87K
Common Stock Shares Outstanding $76M

yearly Cash Flow (As of Jun 30, 2025)

Field Value (USD)
Operating Cashflow -$69M
Payments For Operating Activities -
Proceeds From Operating Activities -
Change In Operating Liabilities -
Change In Operating Assets -
Depreciation Depletion And Amortization $31K
Capital Expenditures $0
Change In Receivables -
Change In Inventory -
Profit Loss -
Cashflow From Investment -$15M
Cashflow From Financing $107M
Proceeds From Repayments Of Short Term Debt -
Payments For Repurchase Of Common Stock -
Payments For Repurchase Of Equity -
Payments For Repurchase Of Preferred Stock -
Dividend Payout -
Dividend Payout Common Stock -
Dividend Payout Preferred Stock -
Proceeds From Issuance Of Common Stock -
Proceeds From Issuance Of Long Term Debt And Capital Securities Net -
Proceeds From Issuance Of Preferred Stock -
Proceeds From Repurchase Of Equity -
Proceeds From Sale Of Treasury Stock -
Change In Cash And Cash Equivalents -
Change In Exchange Rate -
Net Income -$74M

yearly Income Statement (As of Jun 30, 2025)

Field Value (USD)
Gross Profit -$31K
Total Revenue $0
Cost Of Revenue $31K
Costof Goods And Services Sold $31K
Operating Income -$80M
Selling General And Administrative $18M
Research And Development $62M
Operating Expenses $80M
Investment Income Net -
Net Interest Income $5.5M
Interest Income $5.5M
Interest Expense -
Non Interest Income -
Other Non Operating Income -
Depreciation -
Depreciation And Amortization $31K
Income Before Tax -$74M
Income Tax Expense -
Interest And Debt Expense -
Net Income From Continuing Operations -$74M
Comprehensive Income Net Of Tax -
Ebit -$80M
Ebitda -$80M
Net Income -$74M

RZLT News

RZLT Profile

Rezolute Inc Profile

Sector: HEALTHCARE

Industry: BIOTECHNOLOGY

Rezolute, Inc. is a clinical-stage biopharmaceutical company headquartered in Redwood City, California, dedicated to developing innovative therapies for rare and metabolic diseases. The company boasts a promising pipeline targeting significant unmet medical needs, underpinned by its commitment to scientific advancement and clinical excellence. Through strategic collaborations and a focus on improving patient outcomes, Rezolute is uniquely positioned to make a substantial impact in the biopharmaceutical sector, aiming to transform the treatment landscape for underserved patient populations.

LPTX
+368.57%
$2.05
VHAI
0.00%
$0.00
BYND
+19.00%
$1.02
KTTA
+38.67%
$1.47
NVDA
-1.80%
$177.00
VINE
+10.76%
$0.39
ONDS
-2.36%
$8.24
HBI
-1.82%
$6.47
AMZE
+19.82%
$0.47
TLRY
-21.06%
$0.81
INTC
+10.18%
$40.56
BITF
+12.25%
$3.48
IPG
-1.95%
$24.57
YGMZ
-9.59%
$0.11
AXDX
-61.36%
$0.03
RUBI
-26.17%
$0.15
BMNR
+4.53%
$33.18
CLSK
+12.26%
$15.10
ADAP
-15.14%
$0.05
ASST
-0.88%
$1.12
PLUG
+1.51%
$2.01
SOND
-23.45%
$0.12
SNAP
+0.72%
$7.66
RMBL
+60.50%
$3.21
LNW
-3.71%
$86.22
INHD
-0.97%
$0.22
ADD
-25.47%
$0.05
AAL
+0.86%
$14.05
BIYA
+17.05%
$0.29
CHR
-3.48%
$0.04
TSLA
+0.84%
$430.17
SRM
+53.27%
$10.30
CIFR
+6.26%
$20.35
ONMD
+30.28%
$1.85
BMNU
+8.77%
$8.18
IVP
-20.80%
$0.13
MARA
+6.30%
$11.81
WULF
+4.51%
$15.51
NIO
+0.82%
$5.50
GOOG
-1.03%
$320.28
F
+0.45%
$13.25
TWOH
0.00%
$0.00
BURU
+10.43%
$0.24
GPUS
-8.58%
$0.30
WLGS
-5.57%
$0.04
NFLX
+1.66%
$106.14
MTSR
-0.35%
$70.50
IREN
+2.06%
$48.45
SOFI
+4.31%
$29.72
VALE
+0.79%
$12.61
GOOGL
+0.07%
$320.18
BTBT
+2.58%
$2.38
DEFT
+9.35%
$1.52
ADTX
+21.01%
$3.80
BTG
+3.80%
$4.64
DVLT
-4.69%
$2.03
GRAB
+2.44%
$5.45
ACHR
+4.40%
$7.82
AFMD
-34.94%
$0.18
PFE
0.00%
$25.71
SMX
+250.80%
$61.04
CRCL
+10.02%
$79.92
KWM
+13.63%
$0.75
APLD
+5.05%
$24.94
DNN
-0.19%
$2.55
IBRX
+10.79%
$2.36
VEEE
+45.50%
$2.59
RIOT
+7.82%
$16.13
AMZN
+1.77%
$233.22
AAPL
+0.46%
$278.85
CAN
+9.78%
$1.01
AIIO
-9.09%
$0.70
WBD
+0.50%
$24.00
AG
+12.65%
$15.22
NGD
+6.76%
$8.37
RIG
+2.09%
$4.39
GRYP
-10.38%
$1.38
BAC
+1.28%
$53.67
MODV
-25.22%
$0.43
AMD
+1.53%
$217.53
RIVN
+4.20%
$16.86
KSS
+7.49%
$24.10
BTE
-0.31%
$3.16
SMR
+5.04%
$20.00
WMT
+1.96%
$109.10
TMC
+19.38%
$6.96
PLTR
+1.61%
$168.45
CDE
+6.76%
$17.28
ITUB
+1.82%
$7.80
AGNC
-0.66%
$10.49
CRCA
+19.56%
$4.40
KDLY
+7.20%
$0.49
T
+0.69%
$26.00
AMC
+6.30%
$2.44
NVO
+1.21%
$49.30
CRCG
+20.00%
$2.82
MSTR
+0.87%
$177.18
NVVE
-5.25%
$0.25
SAND
-6.04%
$12.12
BBD
+0.67%
$3.70
LPTX
+368.57%
$2.05
VHAI
0.00%
$0.00
BYND
+19.00%
$1.02
KTTA
+38.67%
$1.47
NVDA
-1.80%
$177.00
VINE
+10.76%
$0.39
ONDS
-2.36%
$8.24
HBI
-1.82%
$6.47
AMZE
+19.82%
$0.47
TLRY
-21.06%
$0.81
INTC
+10.18%
$40.56
BITF
+12.25%
$3.48
IPG
-1.95%
$24.57
YGMZ
-9.59%
$0.11
AXDX
-61.36%
$0.03
RUBI
-26.17%
$0.15
BMNR
+4.53%
$33.18
CLSK
+12.26%
$15.10
ADAP
-15.14%
$0.05
ASST
-0.88%
$1.12
PLUG
+1.51%
$2.01
SOND
-23.45%
$0.12
SNAP
+0.72%
$7.66
RMBL
+60.50%
$3.21
LNW
-3.71%
$86.22
INHD
-0.97%
$0.22
ADD
-25.47%
$0.05
AAL
+0.86%
$14.05
BIYA
+17.05%
$0.29
CHR
-3.48%
$0.04
TSLA
+0.84%
$430.17
SRM
+53.27%
$10.30
CIFR
+6.26%
$20.35
ONMD
+30.28%
$1.85
BMNU
+8.77%
$8.18
IVP
-20.80%
$0.13
MARA
+6.30%
$11.81
WULF
+4.51%
$15.51
NIO
+0.82%
$5.50
GOOG
-1.03%
$320.28
F
+0.45%
$13.25
TWOH
0.00%
$0.00
BURU
+10.43%
$0.24
GPUS
-8.58%
$0.30
WLGS
-5.57%
$0.04
NFLX
+1.66%
$106.14
MTSR
-0.35%
$70.50
IREN
+2.06%
$48.45
SOFI
+4.31%
$29.72
VALE
+0.79%
$12.61
GOOGL
+0.07%
$320.18
BTBT
+2.58%
$2.38
DEFT
+9.35%
$1.52
ADTX
+21.01%
$3.80
BTG
+3.80%
$4.64
DVLT
-4.69%
$2.03
GRAB
+2.44%
$5.45
ACHR
+4.40%
$7.82
AFMD
-34.94%
$0.18
PFE
0.00%
$25.71
SMX
+250.80%
$61.04
CRCL
+10.02%
$79.92
KWM
+13.63%
$0.75
APLD
+5.05%
$24.94
DNN
-0.19%
$2.55
IBRX
+10.79%
$2.36
VEEE
+45.50%
$2.59
RIOT
+7.82%
$16.13
AMZN
+1.77%
$233.22
AAPL
+0.46%
$278.85
CAN
+9.78%
$1.01
AIIO
-9.09%
$0.70
WBD
+0.50%
$24.00
AG
+12.65%
$15.22
NGD
+6.76%
$8.37
RIG
+2.09%
$4.39
GRYP
-10.38%
$1.38
BAC
+1.28%
$53.67
MODV
-25.22%
$0.43
AMD
+1.53%
$217.53
RIVN
+4.20%
$16.86
KSS
+7.49%
$24.10
BTE
-0.31%
$3.16
SMR
+5.04%
$20.00
WMT
+1.96%
$109.10
TMC
+19.38%
$6.96
PLTR
+1.61%
$168.45
CDE
+6.76%
$17.28
ITUB
+1.82%
$7.80
AGNC
-0.66%
$10.49
CRCA
+19.56%
$4.40
KDLY
+7.20%
$0.49
T
+0.69%
$26.00
AMC
+6.30%
$2.44
NVO
+1.21%
$49.30
CRCG
+20.00%
$2.82
MSTR
+0.87%
$177.18
NVVE
-5.25%
$0.25
SAND
-6.04%
$12.12
BBD
+0.67%
$3.70
2025 © AfterPullback LTD

Charts powered by TradingView

Market data may be delayed by 15 minutes or more and is provided by financial exchanges or third-party providers. AfterPullback does not verify or guarantee its accuracy and assumes no responsibility to do so. This website is not operated by a licensed attorney, accountant, or financial advisor. Nothing on this site constitutes financial advice or replaces consultation with a qualified professional who understands your specific circumstances. Always consult a licensed financial advisor before making investment decisions.